Trial Profile
Bixalomer versus calcium carbonate on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a randomized study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary) ; Calcium carbonate
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Acronyms BICOLOR STUDY
- 11 Mar 2014 New trial record